会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Analysis of Saccharide Vaccines Without Interference
    • 没有干扰的糖类疫苗的分析
    • US20080286300A1
    • 2008-11-20
    • US10593005
    • 2005-03-17
    • Angela BardottiDaniela ProiettiStefano Ricci
    • Angela BardottiDaniela ProiettiStefano Ricci
    • A61K39/095G01N33/00G06F19/00A61P31/04
    • G01N33/56911A61K39/095A61K2039/6087G01N30/02G01N33/5308G01N2333/22G01N2400/10Y10T436/143333B01D15/363
    • The invention is based on methods that allow analysis of mixed meningococcal saccharides from multiple serogroups even though they share monosaccharide units. With a combination of saccharides from serogroups C, W135 and Y, the invention analyses sialic acid, glucose and galactose content. The glucose and galactose results are used to directly quantify saccharides from serogroups Y and W135, respectively, and the combined glucose and galactose content is subtracted from the sialic acid content to quantify saccharides from serogroup C. The three serogroups can thus be resolved even though their monosaccharide contents overlap. The three different monosaccharide analyses can be performed on the same material, without interference between the monosaccharides and without interference from any other saccharide materials in the composition (e.g. lyophilisation stabilisers). The method can be used to analyse total and free saccharide in conjugate vaccines and simplifies quality control of vaccines containing capsular saccharides from multiple serogroups.
    • 本发明基于允许分析来自多个血清群的混合脑膜炎球菌糖的方法,即使它们共享单糖单元。 利用来自血清群C,W135和Y的糖的组合,本发明分析唾液酸,葡萄糖和半乳糖含量。 葡萄糖和半乳糖结果分别用于从血清组Y和W135直接定量糖,并从唾液酸含量中减去葡萄糖和半乳糖的含量,从血清群C中定量糖。因此,三个血清群可以解决,即使它们 单糖含量重叠。 三种不同的单糖分析可以在相同的材料上进行,而不影响单糖之间的干扰,并且不受组合物中任何其他糖类物质(例如冻干稳定剂)的干扰。 该方法可用于分析结合疫苗中的总和游离糖,并简化了来自多个血清群的含有荚膜糖的疫苗的质量控制。
    • 2. 发明申请
    • ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE
    • 没有干扰的沙门菌疫苗的分析
    • US20120171241A1
    • 2012-07-05
    • US13418211
    • 2012-03-12
    • Angela BardottiDaniela ProiettiStefano Ricci
    • Angela BardottiDaniela ProiettiStefano Ricci
    • A61K39/385A61P37/04G01N33/48
    • G01N33/56911A61K39/095A61K2039/6087G01N30/02G01N33/5308G01N2333/22G01N2400/10Y10T436/143333B01D15/363
    • The invention is based on methods that allow analysis of mixed meningococcal saccharides from multiple serogroups even though they share monosaccharide units. With a combination of saccharides from serogroups C, W135 and Y, the invention analyses sialic acid, glucose and galactose content. The glucose and galactose results are used to directly quantify saccharides from serogroups Y and W135, respectively, and the combined glucose and galactose content is subtracted from the sialic acid content to quantify saccharides from serogroup C. The three serogroups can thus be resolved even though their monosaccharide contents overlap. The three different monosaccharide analyses can be performed on the same material, without interference between the monosaccharides and without interference from any other saccharide materials in the composition (e.g. lyophilisation stabilisers). The method can be used to analyse total and free saccharide in conjugate vaccines and simplifies quality control of vaccines containing capsular saccharides from multiple serogroups.
    • 本发明基于允许分析来自多个血清群的混合脑膜炎球菌糖的方法,即使它们共享单糖单元。 利用来自血清群C,W135和Y的糖的组合,本发明分析唾液酸,葡萄糖和半乳糖含量。 葡萄糖和半乳糖结果分别用于从血清组Y和W135直接定量糖,并从唾液酸含量中减去葡萄糖和半乳糖的含量,从血清群C中定量糖。因此,三个血清群可以被解决,即使它们 单糖含量重叠。 三种不同的单糖分析可以在相同的材料上进行,而不影响单糖之间的干扰,并且不受组合物中任何其他糖类物质(例如冻干稳定剂)的干扰。 该方法可用于分析结合疫苗中的总和游离糖,并简化了来自多个血清群的含有荚膜糖的疫苗的质量控制。
    • 3. 发明授权
    • Analysis of saccharide vaccines without interference
    • 分析糖类疫苗无干扰
    • US08137680B2
    • 2012-03-20
    • US10593005
    • 2005-03-17
    • Angela BardottiDaniela ProiettiStefano Ricci
    • Angela BardottiDaniela ProiettiStefano Ricci
    • A61K39/095G01N31/00G01N31/02G01N21/00G01N30/02G01J3/42
    • G01N33/56911A61K39/095A61K2039/6087G01N30/02G01N33/5308G01N2333/22G01N2400/10Y10T436/143333B01D15/363
    • The invention is based on methods that allow analysis of mixed meningococcal saccharides from multiple serogroups even though they share monosaccharide units. With a combination of saccharides from serogroups C, W135 and Y, the invention analyses sialic acid, glucose and galactose content. The glucose and galactose results are used to directly quantify saccharides from serogroups Y and W135, respectively, and the combined glucose and galactose content is subtracted from the sialic acid content to quantify saccharides from serogroup C. The three serogroups can thus be resolved even though their monosaccharide contents overlap. The three different monosaccharide analyses can be performed on the same material, without interference between the monosaccharides and without interference from any other saccharide materials in the composition (e.g. lyophilisation stabilisers). The method can be used to analyse total and free saccharide in conjugate vaccines and simplifies quality control of vaccines containing capsular saccharides from multiple serogroups.
    • 本发明基于允许分析来自多个血清群的混合脑膜炎球菌糖的方法,即使它们共享单糖单元。 利用来自血清群C,W135和Y的糖的组合,本发明分析唾液酸,葡萄糖和半乳糖含量。 葡萄糖和半乳糖结果分别用于从血清组Y和W135直接定量糖,并从唾液酸含量中减去葡萄糖和半乳糖的含量,从血清群C中定量糖。因此,三个血清群可以被解决,即使它们 单糖含量重叠。 三种不同的单糖分析可以在相同的材料上进行,而不影响单糖之间的干扰,并且不受组合物中任何其他糖类物质(例如冻干稳定剂)的干扰。 该方法可用于分析结合疫苗中的总和游离糖,并简化了来自多个血清群的含有荚膜糖的疫苗的质量控制。